2021
DOI: 10.1016/j.jvs.2021.01.048
|View full text |Cite
|
Sign up to set email alerts
|

Early outcomes associated with use of the Zenith TX2 Dissection Endovascular Graft for the treatment of Stanford type B aortic dissection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 31 publications
0
5
0
Order By: Relevance
“…In another report from a prospective, nonrandomized dissection trial, 5-year outcomes for the Valiant Captivia endograft (Medtronic) included positive and sustained aortic remodeling (8). Results of the multicenter Zenith TX2 dissection endovascular graft study also were recently reported (9); in this study of 120 patients with complicated or uncomplicated type B aortic dissection, treated in the acute, subacute, or chronic phase, mortality was 6.6% in the acute cases with 4.2% permanent paraplegia and 2.5% stroke. No permanent paraplegia or permanent dialysis was reported in patients treated with concurrent placement of the Zenith Dissection Bare Stent.…”
Section: Clinical Results and Advantagesmentioning
confidence: 99%
“…In another report from a prospective, nonrandomized dissection trial, 5-year outcomes for the Valiant Captivia endograft (Medtronic) included positive and sustained aortic remodeling (8). Results of the multicenter Zenith TX2 dissection endovascular graft study also were recently reported (9); in this study of 120 patients with complicated or uncomplicated type B aortic dissection, treated in the acute, subacute, or chronic phase, mortality was 6.6% in the acute cases with 4.2% permanent paraplegia and 2.5% stroke. No permanent paraplegia or permanent dialysis was reported in patients treated with concurrent placement of the Zenith Dissection Bare Stent.…”
Section: Clinical Results and Advantagesmentioning
confidence: 99%
“…The bare metal extension stent technique was developed to extend thoracic TEVAR devices; however, it has been mainly used in acute settings because encouraging aortic remodeling is particularly challenging in the subacute/chronic state when the intimal flap is thicker, and obliterating the false lumen is more difficult. 8 …”
Section: Discussionmentioning
confidence: 99%
“…The bare metal extension stent technique was developed to extend thoracic TEVAR devices; however, it has been mainly used in acute settings because encouraging aortic remodeling is particularly challenging in the subacute/chronic state when the intimal flap is thicker, and obliterating the false lumen is more difficult. 8 The provisional extension to induce complete attachment (PETTICOAT) stent technique to treat acute type B aortic dissection has demonstrated efficacy in expanding the true lumen in the abdominal aorta. 12,13 Systematic reviews by Rong and colleagues 13 and Bertoglio and colleagues 14 both reported improved remodeling of the distal thoracoabdominal aorta at 12 months using the PETTICOAT technique, although studies were nonrandomized and primarily focused on patients with acute Debakey IIIb dissection with malperfusion.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As to Type B aortic dissection (TBAD) have a 30-day mortality rate of up to 25%. Even in the absence of these complications, a diagnosis of type B dissection is associated with a 10% in-hospital mortality [9]. TBAD is a serious condition that need to be treated if complications such as impending rupture, rapid dilation, intractable pain, hypertension, and, in particular, organ or limb malperfusion are present.…”
Section: Introductionmentioning
confidence: 99%